EP 3083991 A1 20161026 - BIOMARKERS FOR HBV TREATMENT RESPONSE
Title (en)
BIOMARKERS FOR HBV TREATMENT RESPONSE
Title (de)
BIOMARKER FÜR DAS ANSPRECHEN AUF EINE HBV-BEHANDLUNG
Title (fr)
BIOMARQUEURS POUR LA RÉPONSE AU TRAITEMENT DU VIRUS DE L'HÉPATITE B
Publication
Application
Priority
- EP 13197711 A 20131217
- EP 2014077667 W 20141215
- EP 14820805 A 20141215
Abstract (en)
[origin: WO2015091306A1] The present invention relates to methods that are useful for predicting the response of hepatitis B virus (HBV) infected patients to pharmacological treatment.
IPC 8 full level
C12Q 1/68 (2006.01)
CPC (source: EP KR US)
A61K 38/212 (2013.01 - EP US); A61P 31/20 (2017.12 - EP); C07K 14/34 (2013.01 - EP US); C12P 13/005 (2013.01 - EP US); C12Q 1/6883 (2013.01 - EP KR US); C12Q 1/706 (2013.01 - EP KR US); C12Y 401/01015 (2013.01 - EP US); C12Q 2600/106 (2013.01 - EP KR US); C12Q 2600/156 (2013.01 - EP KR US); C12Q 2600/158 (2013.01 - US)
Citation (search report)
See references of WO 2015091306A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2015091306 A1 20150625; CA 2929439 A1 20150625; CN 105829548 A 20160803; EP 3083991 A1 20161026; EP 3083991 B1 20180314; JP 2017502663 A 20170126; KR 20160091354 A 20160802; MX 2016007884 A 20161007; RU 2016129060 A 20180123; US 2016298194 A1 20161013; US 2018201997 A9 20180719
DOCDB simple family (application)
EP 2014077667 W 20141215; CA 2929439 A 20141215; CN 201480068549 A 20141215; EP 14820805 A 20141215; JP 2016540600 A 20141215; KR 20167015775 A 20141215; MX 2016007884 A 20141215; RU 2016129060 A 20141215; US 201615184764 A 20160616